TAK‑242 exerts a neuroprotective effect via suppression of the TLR4/MyD88/TRIF/NF‑κB signaling pathway in a neonatal hypoxic‑ischemic encephalopathy rat model

MLA

Hui Li, et al. “TAK‑242 Exerts a Neuroprotective Effect via Suppression of the TLR4/MyD88/TRIF/NF‑κB Signaling Pathway in a Neonatal Hypoxic‑ischemic Encephalopathy Rat Model.” Molecular Medicine Reports, vol. 22, June 2020, pp. 1440–48. EBSCOhost, https://doi.org/10.3892/mmr.2020.11220.

APA

Hui Li, Liu Shunying, Lijun Jiang, Xing Feng, Fudong Wang, Mingfu Wu, Xu Zhenxing, & Jianlan Tao. (2020). TAK‑242 exerts a neuroprotective effect via suppression of the TLR4/MyD88/TRIF/NF‑κB signaling pathway in a neonatal hypoxic‑ischemic encephalopathy rat model. Molecular Medicine Reports, 22, 1440–1448. https://doi.org/10.3892/mmr.2020.11220

Chicago

Hui Li, Liu Shunying, Lijun Jiang, Xing Feng, Fudong Wang, Mingfu Wu, Xu Zhenxing, and Jianlan Tao. 2020. “TAK‑242 Exerts a Neuroprotective Effect via Suppression of the TLR4/MyD88/TRIF/NF‑κB Signaling Pathway in a Neonatal Hypoxic‑ischemic Encephalopathy Rat Model.” Molecular Medicine Reports 22 (June): 1440–48. doi:10.3892/mmr.2020.11220.